Jiang Qiuhui, Lin Zhijuan, Chen Qinwei, Lin Feng, Jiang Chong, Deng Manman, Zha Jie, Liu Long, Ding Chongyang, Xu Bing
Department of Hematology, the First Affiliated Hospital of Xiamen University and Institute of Hematology, School of Medicine, Xiamen University, Xiamen, China.
Key Laboratory of Xiamen for Diagnosis and Treatment of Hematological Malignancy, Xiamen, China.
Quant Imaging Med Surg. 2025 Mar 3;15(3):2468-2480. doi: 10.21037/qims-24-1504. Epub 2025 Feb 19.
Patients with follicular lymphoma (FL) who experience progression of disease within 24 months (POD24) of receiving first-line therapy had a significantly poorer prognosis than that without early progression. Due to the established prognostic relevance of positron emission tomography/computed tomography (PET/CT) parameters in FL and their clinical accessibility, we aimed to investigate the predictive role of PET/CT metabolism and dissemination parameters in POD24 for FL.
The POD24 status of 155 patients who underwent PET/CT examinations at initial diagnosis was evaluated. Various baseline characteristics were collected, along with PET/CT-derived parameters, including the maximum tumor dissemination (Dmax), maximum standardized uptake (SUVmax) value, total metabolic tumor volume (TMTV), and total lesion glycolysis (TLG). A Cox proportional regression analysis was used to identify potential risk predictors of POD24. Receiver operating characteristic (ROC) curves were used to define the optimal cut-off values.
In our cohort, POD24 was observed in 21 (13.5%) FL patients. The univariate and multivariate Cox regression analyses revealed that elevated lactate dehydrogenase (LDH) was a significant predictor of POD24. Additionally, survival analyses based on the cut-off values showed that the risk of POD24 was significantly increased in patients with a Dmax >64.24 cm, SUVmax >11.23, TMTV >144.16 cm, and TLG >586.79 g. Further, a Dmax >64.24 cm, a TMTV >144.16 cm, and elevated LDH were selected for inclusion in a risk model [concordance index (C-index) =0.82], and the patients were divided into three risk groups, in which the rates of POD24 were 1.69%, 10.42%, and 35.29%, respectively (P<0.001). Our model exhibited excellent performance in terms of both the C-index and ROC curve analysis, surpassing the performance of models commonly used in the field.
PET/CT parameters have prognostic value for POD24 in FL. The risk model, which combined PET/CT parameters with clinical indicators, could improve risk stratification and help guide therapeutic decisions.
滤泡性淋巴瘤(FL)患者在接受一线治疗后24个月内出现疾病进展(POD24),其预后明显比无早期进展的患者差。鉴于正电子发射断层扫描/计算机断层扫描(PET/CT)参数在FL中已确立的预后相关性及其临床可及性,我们旨在研究PET/CT代谢和播散参数在FL的POD24中的预测作用。
评估了155例在初始诊断时接受PET/CT检查的患者的POD24状态。收集了各种基线特征以及PET/CT衍生参数,包括最大肿瘤播散(Dmax)、最大标准化摄取值(SUVmax)、总代谢肿瘤体积(TMTV)和总病变糖酵解(TLG)。采用Cox比例回归分析确定POD24的潜在风险预测因素。使用受试者工作特征(ROC)曲线确定最佳临界值。
在我们的队列中,21例(13.5%)FL患者出现POD24。单因素和多因素Cox回归分析显示,乳酸脱氢酶(LDH)升高是POD24的显著预测因素。此外,基于临界值的生存分析表明,Dmax>64.24 cm、SUVmax>11.23、TMTV>144.16 cm和TLG>586.79 g的患者发生POD24的风险显著增加。此外,选择Dmax>64.24 cm、TMTV>144.16 cm和LDH升高纳入风险模型[一致性指数(C指数)=0.82],并将患者分为三个风险组,其中POD24的发生率分别为1.69%、10.42%和35.29%(P<0.001)。我们的模型在C指数和ROC曲线分析方面均表现出优异的性能,超过了该领域常用模型的性能。
PET/CT参数对FL的POD24具有预后价值。将PET/CT参数与临床指标相结合的风险模型可以改善风险分层并有助于指导治疗决策。